Skip to main content
HCPCS J9200 · Level II · Part B drug

J9200: floxuridine, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J9200

Billing unit
500 MG
Floxuridine injection
ASP payment limit
$4,389.848
October 2026; -0.2% vs July 2026
Practitioner MUE
5
MAI 3
OPPS status
SI K
APC 0827
NCCI exposure
no PTP pairs
Coverage articles
1
7 states

TL;DR

HCPCS J9200 is the Level II code for Injection, floxuridine, 500 mg, billed per 500 MG. The Medicare Part B ASP payment limit for October 2026 is $4,389.848 per billing unit, down 0.2% from July 2026. The practitioner MUE allows up to 5 units per date of service (MAI 3), so a full 5-unit day is $21,949.24 at the current limit. Under OPPS it carries status indicator K in APC 0827. J9200 is billed in units of 500 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 1 NDC to it, sold as Floxuridine by JND Therapeutics. 1 Medicare coverage article lists the code across 7 states, including A56695.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J9200 at $4,389.848 per 500 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $4,396.492 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J9200
QuarterPayment limitPerCoinsurance
October 2026$4,389.848500 MG20%
July 2026$4,396.492500 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 1 NDC from 1 labeler to J9200. Report the NDC in the claim's drug segment and bill the number of J9200 units that equals the quantity administered divided by 500 MG; the last column gives units per full package.

NDCs that crosswalk to J9200
NDCDrug nameLabelerPackage sizeBilling units / package
81643-9270-01FloxuridineJND Therapeutics1 × 11

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J9200. For practitioners the limit is 5 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J9200 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services53 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital203 Date of Service Edit: ClinicalClinical: Data
DME supplier163 Date of Service Edit: ClinicalClinical: Data

MUE for J9200 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J9200 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J9200 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J9200 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

1 current Medicare Administrative Contractor article lists J9200 in their HCPCS tables, covering 7 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J9200
ArticleTitleContractor(s)StatesRelated LCD
A56695Billing and Coding: Implantable Infusion PumpPalmetto GBAAL GA NC SC TN VA WVL33461

Diagnoses Medicare contractors cover for J9200

One billing and coding article attaches a covered diagnosis list to J9200: 31 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for J9200
ICD-10-CMDescription (FY2027)Articles covering
C18.0Malignant neoplasm of cecum1 of 1
C18.1Malignant neoplasm of appendix1 of 1
C18.2Malignant neoplasm of ascending colon1 of 1
C18.3Malignant neoplasm of hepatic flexure1 of 1
C18.4Malignant neoplasm of transverse colon1 of 1
C18.5Malignant neoplasm of splenic flexure1 of 1
C18.6Malignant neoplasm of descending colon1 of 1
C18.7Malignant neoplasm of sigmoid colon1 of 1
C18.8Malignant neoplasm of overlapping sites of colon1 of 1
C18.9Malignant neoplasm of colon, unspecified1 of 1
C19Malignant neoplasm of rectosigmoid junction1 of 1
C20Malignant neoplasm of rectum1 of 1
C21.0Malignant neoplasm of anus, unspecified1 of 1
C21.1Malignant neoplasm of anal canal1 of 1
C21.2Malignant neoplasm of cloacogenic zone1 of 1
16 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J9200 are counted here: a group whose instructions name J9200, together with any unnamed groups directly after it, read as continuations of those instructions. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J9200, by article
ArticleContractorGroups that applyCovered codes for J9200Full list
A56695Palmetto GBAgroup 1 applies to J920031On LCD L33461

Local coverage policies that list J9200

2 active Local Coverage Determinations list J9200 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J9200 carries status indicator K and is assigned to APC 0827, with a published national unadjusted payment of $4,389.848. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J9200 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $4,389.85 per 500 MG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J9200 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J9200

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J9200

What does HCPCS code J9200 describe?

J9200 is defined by CMS as "Injection, floxuridine, 500 mg". Each billing unit represents 500 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J9200 a CPT code?

No. J9200 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as floxuridine; CPT codes are five-character codes maintained by the AMA. On a Part B claim J9200 reports the drug itself in 500 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J9200 in October 2026?

The ASP-based payment limit is $4,389.848 per 500 MG, with 20% beneficiary coinsurance. The July 2026 limit was $4,396.492. Commercial payers use their own fee schedules.

How many units of J9200 can be billed per day?

The practitioner Medically Unlikely Edit is 5 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 20. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J9200?

The October 2026 ASP crosswalk lists 1 NDC from 1 labeler: Floxuridine (JND Therapeutics). For example NDC 81643-9270-01 (package size 1) equals 1 billing unit of J9200.

Does J9200 have NCCI bundling edits?

No active practitioner PTP pairs list J9200 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention J9200?

1 current Billing and Coding Article in the Medicare Coverage Database lists J9200, covering 7 states: A56695 (Billing and Coding: Implantable Infusion Pump).

What diagnosis codes support J9200?

One Medicare billing and coding article lists 31 covered ICD-10-CM codes for J9200, for example C18.0 (Malignant neoplasm of cecum); C18.1 (Malignant neoplasm of appendix); C18.2 (Malignant neoplasm of ascending colon); C18.3 (Malignant neoplasm of hepatic flexure); C18.4 (Malignant neoplasm of transverse colon). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.